The erythrocytic merozoite invasion process is one of the promising targets for developing vaccine against malaria, and merozoite surface protein-1 (MSP-1), a polypeptide of 190–230 kDa, has been widely considered as a component of malaria vaccine [16,17]. The gene discussed is ATAD1; the disease is malaria.